DDIT3
DDIT3, also known as CHOP, CHOP10 and GADD153, encodes a C/EBP family transcription factor that acts as a dominant-negative inhibitor of other C/EBP proteins. It is activated by endoplasmic reticulum stress and promotes apoptosis. Browse Assay Genie's current range of DDIT3 research reagents below, or read on for the biology behind the target.
The DDIT3 gene (DNA damage inducible transcript 3) encodes a member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors. The protein works as a dominant-negative inhibitor. It forms heterodimers with other C/EBP members, such as C/EBP and LAP (liver activator protein), and this prevents them from binding DNA. DDIT3 is activated by endoplasmic reticulum stress and promotes apoptosis. It has also been implicated in adipogenesis and erythropoiesis, so it is studied in both stress biology and differentiation.
The UniProt entry linked to this gene (P0DPQ6) describes a different, small product: the protein made from the upstream open reading frame (uORF) of DDIT3/CHOP. This product is produced specifically in the absence of stress, and it prevents translation of the downstream stress effector DDIT3/CHOP. The uORF mechanism therefore holds back the stress effector under basal conditions. UniProt lists the protein in the nucleus and cytoplasm. NCBI Gene reports multiple alternatively spliced transcript variants that encode two isoforms of different length. HGNC places DDIT3 among the basic leucine zipper proteins and also among the microRNA protein coding host genes. Mouse and rat both carry an ortholog named Ddit3.
The gene has several names. CHOP (C/EBP homologous protein), CHOP10 and GADD153 are used in the literature, and the earlier HGNC name was DNA-damage-inducible transcript 3. DDIT3 also matters in cancer genetics. Translocations can fuse the gene to FUS on chromosome 16 or to EWSR1 on chromosome 22. The resulting chimeric proteins are found in myxoid liposarcomas and Ewing sarcoma. Researchers who study the DDIT3 protein or the DDIT3 gene often do so in the context of ER stress signalling, apoptosis and these fusion-driven sarcomas.
DDIT3 is activated by endoplasmic reticulum stress and promotes apoptosis, making it a common readout of stress-induced cell death.
DDIT3 heterodimerises with C/EBP family members and prevents their DNA binding, which makes it a model for dominant-negative control of transcription.
The protein is implicated in adipogenesis and erythropoiesis, linking stress-responsive transcription to cell differentiation.
Translocations joining DDIT3 to FUS or EWSR1 create chimeric proteins in myxoid liposarcoma and Ewing sarcoma.
DDIT3 is a C/EBP family transcription factor that acts as a dominant-negative inhibitor. It forms heterodimers with other C/EBP members and prevents their DNA binding. It is activated by endoplasmic reticulum stress and promotes apoptosis. It is also implicated in adipogenesis and erythropoiesis.
CHOP, CHOP10 and GADD153 are aliases for the same gene. The earlier HGNC name was DNA-damage-inducible transcript 3. NCBI Gene reports transcript variants that encode two isoforms of different length. The UniProt entry P0DPQ6 describes the product of the upstream open reading frame.
Mouse and rat both have an ortholog named Ddit3, so rodent models can be used to study it. In humans, translocations fuse DDIT3 to FUS or EWSR1 and give chimeric proteins in myxoid liposarcomas or Ewing sarcoma. Check the datasheet of any product for its validated reactivity.
Related DNA damage-inducible proteins, C/EBP family members and translocation partners that DDIT3 interacts with or fuses to.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P0DPQ6; product specifications from Assay Genie datasheets.